InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Skelton Laurence Matthew. Officer active across 1 company, notably Vera Therapeutics, Inc.. In total, 2 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €56k. History available since 4 February 2026. The latest transaction was filed on 23 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations